Cadrenal Therapeutics, Inc.

Ownership Transactions Reported by 8 Insiders

Symbol: CVKD on Nasdaq
Industry: Pharmaceutical Preparations
Location: 822 A1 A North, Suite 300, Ponte Vedra, FL

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+20K	100%	$0.70	+$14K
Sells	0
Net	+1	+20K	100%		+$14K

Cadrenal Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Quang Pham	CEO and Chairman, Director, 10%+ Owner	$4.33M			Apr 10, 2024
John R. Murphy	Director	$424K	+$14K	+3.41%	Jan 18, 2024
Matthew K. Szot	Chief Financial Officer	$345K			Jan 18, 2024
Glynn Wilson	Director	$34.5K			Jan 18, 2024
Steven Zelenkofske	Director	$27.6K			Jan 18, 2024
Douglas W. Losordo	Chief Medical Officer				Jan 18, 2024
Robert Lisicki	Director				Jan 18, 2024
Jeffrey Scott Cole	Chief Operating Officer				Apr 2, 2024

Recent Insider Transactions by Companies or Individuals for Cadrenal Therapeutics, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.